Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors
- Tomer Meirson
- , David Bomze
- , Nethanel Asher
- , Omar Hasan Ali
- , Lukas Flatz
- , Daniel Azoulay
- , Gal Markel
- , Tomer Meirson
- Sheba Medical Center at Tel Hashomer
- Tel Aviv University
- Cantonal Hospital St. Gallen
- University of Zurich
Research output: Contribution to journal › Article › peer-review
39
Scopus
citations